← Open Payments lookup

SARA LARSEN: Open Payments

NPI 1609551720 · AMMON, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,260 in 66 payments from 12 companies in 2025. Trend: 2023 $345 · 2024 $881 · 2025 $1,260

Food & beverage: $1,260
CompanyPaymentsAmount
ABBVIE INC.21$332
Axsome Therapeutics, Inc.5$148
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$145
Neurocrine BioSciences, Inc.8$144
Vanda Pharmaceuticals Inc.6$141
Otsuka America Pharmaceutical, Inc.7$135
Alkermes, Inc.3$79
Teva Pharmaceuticals USA, Inc.4$62
Lundbeck LLC1$21
E.R. Squibb & Sons, L.L.C.1$20

Products named: VRAYLAR, Auvelity, CAPLYTA, INGREZZA, FANAPT, REXULTI, ABILIFY ASIMTUFII, LYBALVI.

Industry payments across ID — which companies pay providers there.